Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE: 002422) revealed the decision to suspend equity acquisition in Lijun International Pharmaceutical (Holding) Co., Ltd. (SEHK: 2005).
Earlier, the intended buyer has inked agreement with Prime United Industries Limited and China Pharmaceutical Company Limited on December 28, 2012 for purchasing 180 million shares in the target company.
Sichuan Kelun promised not to hold talks or work out plans for any form relating to equity acquisition in Lijun International in the future six months.
Source:
http://www.sinocast.com/readbeatarticle.do?id=101298
